日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

第二代口服SARS-CoV-2主蛋白酶抑制剂:COVID-19治疗的临床候选药物

Allerton, Charlotte M N; Arcari, Joel T; Aschenbrenner, Lisa M; Avery, Melissa; Bechle, Bruce M; Behzadi, Mohammad Amin; Boras, Britton; Buzon, Leanne M; Cardin, Rhonda D; Catlin, Natasha R; Carlo, Anthony A; Coffman, Karen J; Dantonio, Alyssa; Di, Li; Eng, Heather; Farley, Kathleen A; Ferre, Rose Ann; Gernhardt, Steven S; Gibson, Scott A; Greasley, Samantha E; Greenfield, Siennah R; Hurst, Brett L; Kalgutkar, Amit S; Kimoto, Emi; Lanyon, Lorraine F; Lovett, Gabrielle H; Lian, Yajing; Liu, Wei; Martínez Alsina, Luis A; Noell, Stephen; Obach, R Scott; Owen, Dafydd R; Patel, Nandini C; Rai, Devendra K; Reese, Matthew R; Rothan, Hussin A; Sakata, Sylvie; Sammons, Matthew F; Sathish, Jean G; Sharma, Raman; Steppan, Claire M; Tuttle, Jamison B; Verhoest, Patrick R; Wei, Liuqing; Yang, Qingyi; Yurgelonis, Irina; Zhu, Yuao

Genetic Surveillance of SARS-CoV-2 M(pro) Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

对SARS-CoV-2 M(pro)的基因监测显示,在引入蛋白酶抑制剂帕洛维之前,其序列和结构高度保守。

Lee, Jonathan T; Yang, Qingyi; Gribenko, Alexey; Perrin, B Scott Jr; Zhu, Yuao; Cardin, Rhonda; Liberator, Paul A; Anderson, Annaliesa S; Hao, Li

Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer

一例新冠肺炎患者持续性细菌合并感染是由基因适应性铜绿假单胞菌慢性定植株引起的

Qu, Jiuxin; Cai, Zhao; Liu, Yumei; Duan, Xiangke; Han, Shuhong; Liu, Jihong; Zhu, Yuao; Jiang, Zhaofang; Zhang, Yingdan; Zhuo, Chao; Liu, Yang; Liu, Yingxia; Liu, Lei; Yang, Liang

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.

替诺福韦的细胞内代谢和体外抗乙型肝炎病毒活性

Delaney William E 4th, Ray Adrian S, Yang Huiling, Qi Xiaoping, Xiong Shelly, Zhu Yuao, Miller Michael D